Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials

OBJECTIVE: The aim of this study was to systematically evaluate the efficacy and safety of the combination of dendritic cells and cytokine-induced killer cells (DC–CIK) adjuvant immunotherapy and chemotherapy in the treatment of multiple myeloma (MM). METHODS: Clinical trials were gathered by search...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Lv, Benji, Li, Ke, Zhang, Anqi, Liu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695269/
https://www.ncbi.nlm.nih.gov/pubmed/29180849
http://dx.doi.org/10.2147/DDDT.S146959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695269/
https://www.ncbi.nlm.nih.gov/pubmed/29180849
http://dx.doi.org/10.2147/DDDT.S146959

Ejemplares similares